A third workplan with measures due by 2025 has been released by the joint Big Data Steering Group of the European Medicines Agency (EMA) as well as the Heads of Medicines Agencies (HMA). The new strategy, according to EMA, will improve the integrated approach of data analysis into the regulatory assessment of pharmaceuticals. The agency […]

The post Big Data Steering Group To Optimize Data Quality, Visibility first appeared on World Pharma Today.